Company: NCEL
Filing Date: 2025-06-16
Form Type: 425
Source: 0001213900-25-054487
Chunk: 5

Company: NewcelX Ltd.
Filing Date: 2025-06-16
Form: 425
Chunk 5
---
 companies; inability to timely develop and introduce new technologies, products and applications;
and loss of market share and pressure on pricing resulting from competition, which could cause the actual results or performance of candidate
products to differ materially from those contemplated in such forward-looking statements. Except as otherwise required by law, neither
Kadimastem nor NLS undertakes any obligation to publicly release any revisions to these forward-looking statements to reflect events or
circumstances after the date hereof or to reflect the occurrence of unanticipated events. More detailed information about the risks and
uncertainties affecting NLS is contained under the heading “Risk Factors” in NLS’s annual report on Form 20-F for the
year ended December 31, 2023, filed with the Securities and Exchange Commission (“SEC”), which is available on the SEC’s
website, www.sec.gov, and in subsequent filings made by NLS with the SEC, including under the heading “Risk Factors” in NLS’s
registration statement on Form F-4, filed with the SEC on December 27, 2024.

<div align='center'>3</div>

No Offer or Solicitation

This communication is not intended to and shall
not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or
approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior
to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made, except by
means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Additional Information about the Transaction and Where to Find It

In connection with the proposed transaction, NLS
filed a registration statement on Form F-4 on December 30, 2023, including a proxy statement/prospectus, with the SEC (the “F-4
Registration Statement”), and subsequent Amendments to the F-4 Registration Statement on March 3, 2025, March 31, 2025, and June
9, 2025. NLS may also file other relevant documents with the SEC regarding the proposed transaction. This document is not a substitute
for the proxy statement/prospectus or any other document that NLS may file with the SEC. The proxy statement (if and when available) will
be mailed or delivered to shareholders of N